z-logo
open-access-imgOpen Access
Leishmania aethiopica Derived from Diffuse Leishmaniasis Patients Preferentially Induce mRNA for Interieukin-10 while Those from Localized Leishmaniasis Patients Induce Interferon-
Author(s) -
Hannah Akuffo,
Kerima Maasho,
M. Blostedt,
Bo Höjeberg,
Sven Britton,
Moiz Bakhiet
Publication year - 1997
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/175.3.737
Subject(s) - cutaneous leishmaniasis , leishmaniasis , leishmania , immunology , interferon , interferon gamma , immunosuppression , leishmania major , biology , tumor necrosis factor alpha , cytokine , antigen , virology , parasite hosting , world wide web , computer science
Exposure of peripheral blood mononuclear cells to promastigotes of Leishmania aethiopica derived from patients with the self-limiting, localized form of the disease (local cutaneous leishmaniasis; LCL) preferentially induced mRNA for interferon (IFN)-gamma but little for interleukin (IL)-10. In contrast, stimulation of the same cells with promastigotes derived from patients with the persistent, disseminated form of the disease (diffuse cutaneous leishmaniasis; DCL) stimulated the expression of IL-10 rather than IFN-gamma. In general, parasites derived from LCL patients induced more expression of other cytokines tested, including IL-4, IL-6, and transforming growth factor-beta, although tumor necrosis factor-alpha was equivalent in cultures stimulated with LCL or DCL promastigotes. The results suggest that the antigen-specific immunosuppression observed in DCL patients and the resulting clinical picture could in part be due to the properties of the infecting parasite to induce more IL-10 than IFN-gamma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom